Your browser doesn't support javascript.
loading
Tasisulam sodium (LY573636 sodium) as third-line treatment in patients with unresectable, metastatic non-small-cell lung cancer: a phase-II study.
Scagliotti, Giorgio V; Ilaria, Robert; Novello, Silvia; von Pawel, J; Fischer, Juergen R; Ermisch, Sabine; de Alwis, Dinesh P; Andrews, Joan; Reck, Martin; Crino, Lucio; Eschbach, Corinna; Manegold, Christian.
Affiliation
  • Scagliotti GV; Department of Clinical & Biological Sciences, University of Torino, Orbassano (Torino), Italy. giorgio.scagliotti@unito.it
J Thorac Oncol ; 7(6): 1053-7, 2012 Jun.
Article in En | MEDLINE | ID: mdl-22588156

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Benzamides / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Neoplasm Staging Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Thorac Oncol Year: 2012 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Benzamides / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Neoplasm Staging Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Thorac Oncol Year: 2012 Type: Article Affiliation country: Italy